30 / 68
186
P.J. Curi-Curi et al. / Cir Cardiov. 2016;
23(4)
:179–186
4. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenowelh DE, Pacifico AD.
Complement and the damaging effects of cardiopulmonary bypass. J Thorac
Cardiovasc Surg. 1983;86:845–7.
5. Seghaye M, Duchateau J, Grabitz RG, Nitsch G, Marcus C, Messmer BJ, et al. Com-
plement, leukocytes and leukocyte elastase in full-term neonates undergoing
cardiac operation. J Thorac Cardiovasv Surg. 1994;108:29–36.
6. Seghaye M, Grabitz RG, Duchateau J, Bussea S, Däbritz S, Koch D, et al.
Inflammatory reaction and capillary leak syndrome related to cardiopulmonary
bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg.
1996;112:687–97.
7. Ashraf SS, Tian Y, Zacharrias S, Cowan D, Martin P, Watterson K. Effects of car-
diopulmonary bypass on neonatal and paediatric inflammatory profiles. Eur J
Cardiothorac Surg. 1997;12:862–8.
8. McBride WT, McBride SJ. The balance of pro- and anti-inflammatory cytokines
in cardiac surgery. Curr Opin Anesthesiol. 1998;11:15–22.
9. McBride WT, Armstrong MA, Gilliland H, McMurray TJ. The balance of pro- and
anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at
paediatric cardiac surgery. Cytokine. 1996;8:724–9.
10. Chevv M, Brandslund I, Brix-Christensen V, Ravn H, Hjortdal V, Pedersen J, et al.
Tissue injury and the inflammatory response to pediatric cardiac surgery with
cardiopulmonary bypass. Anesthesiology. 2001;94:745–53.
11. Finn A, Moat N, Rebuck N, Klein N, Slrobel S, Elliott M. Changes in neutrophil
CDllb/CD18 and L-selectin expression and release of interleukin 8 and elastase
in paediatric cardiopulmonay bypass. Agents Actions. 1993;38:C44–6.
12. Brix-Christensen V, Petersen TK, Ravn HB, Hjortdal VE, Andersen NR, Ton-
nesen E. Cardiopulmonary bypass elicits a pro- and anti-inflammatory
response and impaired chemotaxis in neonatal pigs. Acta Anaesthesiol Scand.
2001;45:407–13.
13. Hennein HA, Kiseltepe U, Barst S, Bocchieri KA, Remick DG, Gold JP, et al.
Venovenous modified ultrafiltration after cardiopulmonary bypass in chil-
dren: A prospective randomized study. J Thorac Cardiovasc Surg. 1999;117:
496–505.
14. Hauser GJ, Ben-Ari J, ColvinMP, DaltonHJ, Hertzog JH, BearbM, et al. Interleukin-
6 levels in serumand lung lavage fluid of children undergoing open heart surgery
correlate with postoperative morbidity. Int Care Med. 1998;24:481–6.
15. Gilliland HE, Armstrong MA, McMurray TJ. The inflammatory response to pedia-
tric cardiac surgery: Correlation of granulocyte adhesion molecule expression
with postoperative oxygenation. Anest Analg. 1999;89:1188–91.
16. Andreasson S, Góthberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemo-
filtration modifies complement activation after extracorporeal circulation in
infants. Ann Thorac Surg. 1993;56:1515–7.
17. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during
cardiopulmonary bypass. Ann Thorac Surg. 1992;54:541–6.
18. Boga M, Islamoglu F, Badak I, Cikirikcioglu M, Bakalim T, Yagdi T. The effects of
modified hemofiltration on inflammatory mediators and cardiac performance
in coronary artery bypass grafting. Perfusion. 2000;15:143–50.
19. Tassani P, Richter JA, Eising GP, Barabkay A, Braun SL, Haehnel CH, et al.
Influence of combined zero-balanced and modified ultrafiltration on the
systemic inflammatory response during coronary artery bypass grafting. Car-
diothorac VascAnesth. 1999;13:285–91.
20. Pearl JM, Manning PB, McNamara JL, Saucier MM, Thomas DW. Effect
of modified ultrafiltration on plasma thromboxane B2, leukotriene B4,
endothelin-1 in infants undergoing cardiopulmonary bypass. Ann Thorac Surg.
1999;68:1369–75.
21. Grunenfelder J, Sund G, Schoeberlein A, Maly FE, Guntli S, Fischer K, et al.
Modified ultrafiltration lowers adhesion molecule and cytokine levels after car-
diopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac
Surg. 2000;17:77–83.
22. Chew MS. Does modified ultrafiltration reduce the systemic inflamma-
tory response to cardiac surgery with cardiopulmonary bypass. Perfusion.
2004;19:S57–60.
23. Wang W, Chiu I, Chao-Min W, Pei-Lin L, Huand HM, Chung-I C, et al. Modified
ultrafiltration in pediatric cardiopulmonary bypass. Perfusion. 1998;13:304–10.
24. Ming-JiuhW, Ing-Sh Chiu Chao-MingW, Pei-Lin L, Chung-I C, Chi-Hsiang H, Shu-
Hsun C. Efficacy of ultrafiltration in removing inflammatory mediators during
pediatric cardiac operations. Ann Thorac Surg. 1996;61:651–6.
25. Naik S, Knight A, ElliottMJ. Aprospective randomized study of amodified techni-
que of ultrafiltration during pediatric open-heart surgery. Circulation. 1991;84
Suppl III:422–31.
26. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Auto-
immun. 2003;20(4):281–5.
27. Bando K, Turrentine MW, Vijay P, Sharp TG, Lalone BJ, Szekely L, et al. Effect of
modified ultrafiltration in high-risk patients undergoing operations for conge-
nital heart disease. Ann Thorac Surg. 1998;66:821–8.
28. Draasima AM, Hazekamp MG, Frank M, Anes N, Schoof PH, Huysmans HA. Modi-
fied ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery.
Ann Thorac Surg. 1997;64:521–5.
29. Daggett CW, Lodge AJ, Scarborough JE, Chai PJ, Jaggers J, Ungerleider RM.
Modified ultrafiltration versus conventional ultrafiltration: A randomized pros-
pective study in neonatal piglets. J Thorac Cardiovasc Surg. 1998;H5:336–42.
30. DaviesMJ, NguyenK, Gaynor JW, ElliottMJ. Modified ultrafiltration improves left
ventricular systolic function in infants after cardiopulmonary bypass. J Thorac
Cardiovasc Surg. 1998;5:361–70.
31. Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhe P, et al. High-
volume, zero-balanced hemofiltration to reduce delayed inflammatory response
to cardiopulmonary bypass in children. Anesthesiology. 1996;85:965–76.
32. Chew MS, Brix-Christensen V, Ravn H, Brandslund I, Ditlevsen E, Pedersen
J, et al. Effect of modified ultrafiltration on the inflammatory response in
paediatric open-heart surgery: A prospective, randomized study. Perfusion.
2002;17:327–33.
33. Ramamoorthy C, Lynn AM. The use of modified ultrafiltration during pedia-
tric cardiovascular surgery is not a benefit. Cardiothorac Vasc Anesthesia.
1998;12(4):483–5.
34. García-Montes JA, Calderón-Colmenero J, Juanico A. Cuidados intensivos en el
ni˜no cardiópata. En: Attie F, Calderón-Colmenero J, Zabal C, Buendía A, editores.
Cardiología pediátrica. MéxicoD.F: Editorial Médica Panamericana; 2013. p. 203.
35. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, et al.
Serum lactate as a predictor of mortality in emergency department patients
with infection. Ann Emerg Med. 2005;45:524–8.
36. Trzeciak S. Lac-time. Crit Care Med. 2004;32:1785–6.